PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
42.94
ESG score below 80% of Biotechnology median of 59.90. Michael Burry would check for potential stranded assets and regulatory compliance issues.
50.00
Environmental score 90-95% of Biotechnology median of 55.23. John Neff would demand higher returns to compensate for below-average climate risk management.
29.13
Social score below 80% of Biotechnology median of 61.84. Michael Burry would check for potential boycott risks and regulatory compliance issues.
49.69
Governance score 80-90% of Biotechnology median of 61.45. Martin Whitman would look for hidden agency costs and management entrenchment risks.